Although this guidance does not specifically address the submission of analytical procedures and validation data for raw materials, intermediates, excipients, container closure components, and other materials used in the production of drug substances and
详情正文
登录后查看完整内容
使用 DeepEvidence / 梅斯账号登录，新用户可在登录页面注册。
登录 / 注册登录成功后将返回当前页面，继续浏览。